1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 0,560 | 0,635 | 22.01. |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | RAFFLES MEDICAL GROUP LTD: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::NOTIFICATION OF RESULTS RELEASE | 2 | SGX Company Announcements | ||
| 30.12.24 | RAFFLES MEDICAL GROUP LTD: CHANGE - ANNOUNCEMENT OF APPOINTMENT::RE-DESIGNATION OF MR TAN SOO NAN TO NON-EXECUTIVE AND NON-INDEPENDENT DIRECTOR | 2 | SGX Company Announcements | ||
| 27.11.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 25.11.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 19.11.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | - | SGX Company Announcements | ||
| RAFFLES MEDICAL Aktie jetzt für 0€ handeln | |||||
| 12.11.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | - | SGX Company Announcements | ||
| 12.11.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER(S)/ UNITHOLDER(S)::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF SUBSTANTIAL SHAREHOLDER | - | SGX Company Announcements | ||
| 10.11.24 | RAFFLES MEDICAL GROUP LTD: CHANGE - ANNOUNCEMENT OF CESSATION::CHANGE - ANNOUNCEMENT OF CESSATION | - | SGX Company Announcements | ||
| 01.11.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 30.10.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 26.09.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 24.09.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 4 | SGX Company Announcements | ||
| 03.09.24 | RAFFLES MEDICAL GROUP LTD: REPL::EMPLOYEE STOCK OPTION/ SHARE SCHEME::EMPLOYEE STOCK OPTION/SHARE SCHEME | 1 | SGX Company Announcements | ||
| 02.09.24 | RAFFLES MEDICAL GROUP LTD: EMPLOYEE STOCK OPTION/ SHARE SCHEME::GRANT OF AWARDS/SHARE OPTIONS PURSUANT TO THE RMG (2020) PERFORMANCE SHARE PLAN/SHARE OPTION SCHEME | 1 | SGX Company Announcements | ||
| 02.09.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 02.09.24 | RAFFLES MEDICAL GROUP LTD: EMPLOYEE STOCK OPTION/ SHARE SCHEME::EMPLOYEE STOCK OPTION/SHARE SCHEME | 1 | SGX Company Announcements | ||
| 13.08.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | - | SGX Company Announcements | ||
| 07.08.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 05.08.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements | ||
| 01.08.24 | RAFFLES MEDICAL GROUP LTD: DISCLOSURE OF INTEREST/ CHANGES IN INTEREST OF DIRECTOR/ CHIEF EXECUTIVE OFFICER::DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER | 1 | SGX Company Announcements |
Seite:
1 2 Weiter >>
23 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 53,96 | +0,33 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 53 Euro auf "Neutral" belassen. Im europäischen Medizintechnik-Bereich gebe... ► Artikel lesen | |
| FRESENIUS | 35,910 | -0,83 % | Leichte Zugewinne bei der Fresenius SE & Co. KGaA-Aktie (36,58 €) | Das Wertpapier von Fresenius SE & Co. KGaA notiert heute fester. Der jüngste Kurs betrug 36,58 Euro. Die Fresenius+Co KgaA-Aktie verzeichnet gegenwärtig einen Wertanstieg von 2,75 Prozent. Sie hat sich... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 44,460 | +0,27 % | Fresenius Medical Care Aktie: Richtung stimmt! | Die Fresenius Medical Care-Aktie setzt ihren positiven Trend fort und verzeichnet am 19. Januar 2025 einen Kursanstieg von 0,04 Prozent auf 44,88 EUR. Die Entwicklung der vergangenen Wochen zeigt eine... ► Artikel lesen | |
| GERRESHEIMER | 65,70 | -2,01 % | EQS-PVR: Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Gerresheimer AG
Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 49,500 | +1,43 % | Neue 14,25% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VG2U1Q5/ WKN VG2U1Q) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 68,42 | 0,00 % | PROCEPT BioRobotics (NASDAQ:PRCT) Trading Down 2.8% - Should You Sell? | ||
| BRIGHTSPRING HEALTH SERVICES | 21,210 | 0,00 % | BrightSpring Health Services, Inc. Enters into Definitive Agreement to Divest Community Living Business to Sevita; Reports Preliminary 2024 Financial Results and Provides 2025 Guidance Excluding Community Living | Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic... ► Artikel lesen | |
| UNITEDHEALTH | 498,15 | 0,00 % | Rekordjahr geplant: UnitedHealth bleibt Marktführer | Die Aktie der UnitedHealth Group profitiert von den jüngsten Quartalsergebnissen. Rekordumsätze, eine wachsende Kundenbasis und solide operative Margen zeichnen das Geschäftsjahr aus, während Herausforderungen... ► Artikel lesen | |
| NANO-X IMAGING | 8,980 | 0,00 % | Nano-X Imaging LTD.: Nanox.ARC Imaging System Receives FDA Clearance for General Use, Including Pulmonary Indication | Nanox.ARC receives additional FDA clearance to produce tomographic images for general use, including pulmonary, intra-abdominal and paranasal indications, in addition to its previously cleared indication... ► Artikel lesen | |
| INTUITIVE SURGICAL | 585,70 | -0,12 % | Intuitive Surgical: Dr. Robot ist nicht zu stoppen - neues Rekordhoch | Der Weltmarktführer für Roboter-assistierte Technologien hat am Mittwoch vorläufige Zahlen für das vierte Quartal respektive Gesamtjahr 2024 vorgelegt. Und diese können sich sehen lassen. Die Aktie... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 22,680 | -0,18 % | Privia Health Group, Inc.: Privia Health Reports Third Quarter 2024 Financial Results | Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared... ► Artikel lesen | |
| ECKERT & ZIEGLER | 48,520 | +0,50 % | Top-Picks der Profis für 2025: Init, Eckert & Ziegler und Kontron (Teil 3) | Fondsmanager und Vermögensverwalter sind immer ganz nah am Markt. Zum Jahreswechsel habe ich mal bei einigen dieser Strategen nachgefragt, welche Small und Mid Caps sie sich für das Jahr 2025 auf die... ► Artikel lesen | |
| GENEDX | 75,69 | 0,00 % | GeneDx Announces Preliminary 2024 Financial Results | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported preliminary financial results for... ► Artikel lesen | |
| ATRICURE | 39,490 | -0,35 % | Deep Dive Into AtriCure Stock: Analyst Perspectives (9 Ratings) | ||
| PROGYNY | 21,155 | 0,00 % | Witness A Substantial Acquisition As DEBRA MORRIS Acquires Progyny Stock Options Worth $37K |
RAFFLES MEDICAL GROUP LTD gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell -0,88 % bei einem Aktienkurs von 0,560 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu RAFFLES MEDICAL GROUP LTD finden Sie auf Wallstreet Online.
